Innoviva Quarterly Balance Sheet
NASDAQ: INVAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Innoviva financial position
As of Jun 30, 2026, Innoviva reported total assets of $1.70 billion, up 27.7% from a year earlier against total liabilities of $469.5 million. Shareholders' equity stood at $1.23 billion, or 72.4% of assets. The company held $570.4 million in cash and equivalents against $258.5 million of debt, a net cash position of $311.9 million.
The current ratio (current assets divided by current liabilities) was 16.01, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.21.
Summary generated from market data by MetaCap's automated system. Methodology
Innoviva balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 570.39M | 603.09M | 550.94M | 476.51M | 397.53M | 319.09M | 304.96M | 260.63M | 217.00M | 178.36M | 193.51M | 180.00M |
| Inventory | 38.97M | 38.84M | 39.17M | 38.36M | 49.00M | 41.48M | 33.73M | 34.24M | 36.66M | 37.44M | 40.74M | 40.52M |
| Total Current Assets | 753.37M | 772.62M | 727.51M | 684.57M | 651.78M | 582.02M | 554.31M | 400.62M | 358.28M | 311.34M | 344.22M | 305.00M |
| Property, Plant & Equipment | 2.13M | 2.14M | 1.55M | 1.53M | 451.00K | 483.00K | 514.00K | 544.00K | 427.00K | 324.00K | 483.00K | 361.00K |
| Goodwill | 17.91M | 17.91M | 17.91M | 17.91M | 17.91M | 17.91M | 17.91M | 17.91M | 17.91M | 17.91M | 17.91M | 17.91M |
| Intangible Assets | 168.98M | 175.60M | 182.16M | 188.79M | 195.41M | 201.96M | 208.43M | 210.94M | 217.46M | 223.90M | 230.34M | 236.84M |
| Long-Term Investments | 441.31M | 413.08M | 404.50M | 343.79M | 297.28M | 291.10M | 341.66M | 434.17M | 444.65M | 476.55M | 444.43M | 422.49M |
| Total Assets | 1.70B | 1.84B | 1.64B | 1.43B | 1.33B | 1.25B | 1.30B | 1.23B | 1.22B | 1.27B | 1.24B | 1.19B |
| Accounts Payable | 4.02M | 6.52M | 4.97M | 6.24M | 5.38M | 4.70M | 2.13M | 4.17M | 2.04M | 890.00K | 6.72M | 3.78M |
| Short-Term Debt | — | — | 0 | 0 | 191.90M | 192.22M | 192.03M | 191.84M | — | — | 0 | 0 |
| Total Current Liabilities | 47.06M | 36.56M | 49.70M | 48.47M | 246.56M | 234.75M | 236.08M | 223.75M | 28.21M | 29.88M | 38.13M | 36.18M |
| Long-Term Debt | 258.45M | 258.10M | 257.73M | 257.38M | 257.02M | 256.67M | 256.32M | 255.97M | 447.28M | 446.76M | 446.23M | 445.72M |
| Total Liabilities | 469.46M | 494.93M | 462.32M | 419.15M | 618.75M | 607.49M | 609.90M | 563.07M | 559.40M | 563.93M | 568.55M | 560.61M |
| Shareholders' Equity | 1.23B | 1.34B | 1.17B | 1.01B | 714.82M | 646.90M | 691.16M | 668.54M | 665.51M | 703.68M | 674.96M | 627.49M |
| Retained Earnings | 372.54M | 455.96M | 269.37M | 105.22M | 15.31M | -48.38M | -1.80M | -22.13M | -23.34M | 11.34M | -25.19M | -86.72M |
| Total Debt | 258.45M | 258.10M | 257.73M | 257.38M | 448.92M | 448.88M | 448.34M | 447.81M | 447.28M | 446.76M | 446.23M | 445.72M |
| Net Cash (Debt) | 311.93M | 344.99M | 293.21M | 219.14M | -51.39M | -129.79M | -143.38M | -187.19M | -230.28M | -268.40M | -252.72M | -265.72M |
| Shares Outstanding | 72.64M | 73.81M | 74.64M | 74.77M | 63.01M | 62.77M | 62.66M | 62.60M | 62.56M | 62.80M | 63.31M | 64.38M |
This table shows 12 quarterly periods of Innoviva's balance sheet, from Q2 2026 back to Q3 2023, across 20 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow INVA's reporting calendar. What is a balance sheet?